Business
Breckenridge announces launch of Milnacipran HCl Tablets, generic equivalent of Savella®
Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, today announced the launch of Milnacipran HCl Tablets, the generic equivalent of Savella® by AbbVie, in the pain management category.
About this update from Abbvie Inc.
[{"type":"text","content":"BERKELEY HEIGHTS, N.J., March 19, 2026 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, today announced the launch of Milnacipran HCl Tablets, the generic equivalent of Savella® by AbbVie, in the pain management category.","length":347,"tagName":"p"},{"type":"image","alt":"Breckenridge Pharmaceutical, Inc. logo (PRNewsfoto/Breckenridge Pharmaceutical, Inc.)","displaySize":"","headline":null,"caption":"Breckenridge Pharmaceutical, Inc. logo (PRNewsfoto/Breckenridge Pharmaceutical, Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":60,"url":"https://media.zenfs.com/en/prnewswire.com/491b10c60e4d01bd0d0132c42d14d600"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7NoOB9jpT.mgVtdukezDMw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwNg--/https://media.zenfs.com/en/prnewswire.com/491b10c60e4d01bd0d0132c42d14d600","width":400,"height":60}},"href":"https://mma.prnewswire.com/media/2583645/Breckenridge_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"This launch reflects Breckenridge's continued focus on ensuring broad and reliable access to essential therapies for chronic conditions, where stability of supply, product quality, and affordability can directly impact patient well-being and treatment continuity.","length":267,"tagName":"p"},{"type":"text","content":"Milnacipran HCl Tablets are indicated for the management of fibromyalgia. Milnacipran HCl is a potent inhibitor of neuronal norepinephrine and serotonin reuptake; milnacipran inhibits norepinephrine uptake with approximately 3-fold higher potency in vitro than serotonin without directly affecting the uptake of dopamine or other neurotransmitters. Please visit www.breckenridgepharma.com for the full prescribing information including boxed warning, precautions, and adverse reactions.","length":486,"tagName":"p"},{"type":"text","content":"The product is approved for use in adults and is available in 12.5 mg, 25 mg, 50 mg, and 100 mg strengths. Milnacipran HCl Tablets are not approved for use in pediatric patients. Milnacipran HCl Tablets will be manufactured by Breckenridge's partner, Centaur Pharmaceuticals Pvt. Ltd., and primarily distributed through retail and mail order pharmacies.",...